This session explores advanced technologies to explore how genetic changes in non-coding regions impacts molecular phenotypes and disease risk. These diverse approaches include computational predictors to understand cis-regulatory logic, dynamic QTL studies of expression and splicing, and multi-modal single-cell data integrated with chromatin looping.
Learning Objectives: 1. Define epigenetic changes in metabolic dysfunction-associated fatty liver disease. 2. Identify important predictors of chromatin remodeling inhibition. 3. Identify novel genetic variants and splicing events that influence Osteoarthritis. 4. Identify B cell activation dependent expression signatures and QTLs.